AKUS
Price:
$13.29
Market Cap:
$0
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The c...[Read more]
Industry
Biotechnology
IPO Date
2020-06-26
Stock Exchange
NASDAQ
Ticker
AKUS
According to Akouos, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.06. This represents a change of 0.21% compared to the average of 14.03 of the last 4 quarters.
The mean historical Current Ratio of Akouos, Inc. over the last ten years is 13.05. The current 14.06 Current Ratio has changed 10.67% with respect to the historical average. Over the past ten years (40 quarters), AKUS's Current Ratio was at its highest in in the March 2021 quarter at 41.24. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
13.05
Median
9.39
Minimum
4.40
Maximum
29.01
Discovering the peaks and valleys of Akouos, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 559.40%
Maximum Annual Current Ratio = 29.01
Minimum Annual Increase = -51.54%
Minimum Annual Current Ratio = 4.40
Year | Current Ratio | Change |
---|---|---|
2021 | 14.06 | -51.54% |
2020 | 29.01 | 559.40% |
2019 | 4.40 | -7.00% |
The current Current Ratio of Akouos, Inc. (AKUS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
15.82
5-year avg
13.05
10-year avg
13.05
Akouos, Inc.’s Current Ratio is
Company | Current Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akouos, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Akouos, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Akouos, Inc.'s Current Ratio?
How is the Current Ratio calculated for Akouos, Inc. (AKUS)?
What is the highest Current Ratio for Akouos, Inc. (AKUS)?
What is the 3-year average Current Ratio for Akouos, Inc. (AKUS)?
What is the 5-year average Current Ratio for Akouos, Inc. (AKUS)?
How does the current Current Ratio for Akouos, Inc. (AKUS) compare to its historical average?